No Summary

Alnylam’s heart drug troubles take center stage at a cardiology conference - STAT

Alnylam’s heart drug troubles take center stage at a cardiology conference

Sources

• STAT
  Alnylam’s heart drug troubles take center stage at a cardiology conference
• STAT
  In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
• Endpoints News
  Future of AstraZeneca’s gene silencer in heart disease uncertain after trial failure
• Seeking Alpha
  Alnylam drops as AstraZeneca posts full trial results for failed heart drug
• HCPLive
  CARDIO-TTRansform: Eplontersen Misses Primary Endpoint in ATTR-CM